Literature DB >> 20535843

Anticancer drugs: A double strike at kinases.

Charlotte Harrison.   

Abstract

Year:  2010        PMID： 20535843     DOI： 10.1038/nrd3152

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF.

Authors:  Eric A Murphy; David J Shields; Konstantin Stoletov; Elena Dneprovskaia; Michele McElroy; Joshua I Greenberg; Jeff Lindquist; Lisette M Acevedo; Sudarshan Anand; Bharat Kumar Majeti; Igor Tsigelny; Adrian Saldanha; Breda Walsh; Robert M Hoffman; Michael Bouvet; Richard L Klemke; Peter K Vogt; Lee Arnold; Wolfgang Wrasidlo; David A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-12       Impact factor: 11.205
  1 in total
  1 in total

1.  Naringenin suppresses K562 human leukemia cell proliferation and ameliorates Adriamycin-induced oxidative damage in polymorphonuclear leukocytes.

Authors:  Rui-Fang Li; Ying-Qian Feng; Jun-Hui Chen; Lin-Tong Ge; Shu-Yuan Xiao; Xue-Lan Zuo
Journal:  Exp Ther Med       Date:  2015-01-16       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.